BR0214993A - Processo para redução de acne ou aperfeiçoamento de tÈnus de pele - Google Patents

Processo para redução de acne ou aperfeiçoamento de tÈnus de pele

Info

Publication number
BR0214993A
BR0214993A BR0214993-1A BR0214993A BR0214993A BR 0214993 A BR0214993 A BR 0214993A BR 0214993 A BR0214993 A BR 0214993A BR 0214993 A BR0214993 A BR 0214993A
Authority
BR
Brazil
Prior art keywords
acne
skin
reduction
improvement
skin tone
Prior art date
Application number
BR0214993-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Laura Mcculloch
Rachel Grossman
Lynn Halas
Benjamin Wiegand
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/012,627 external-priority patent/US20020146469A1/en
Priority claimed from US10/017,180 external-priority patent/US20020151527A1/en
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of BR0214993A publication Critical patent/BR0214993A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0016—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the smell sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0022—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the tactile sense, e.g. vibrations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0077—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with application of chemical or pharmacological stimulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/04—Skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Acoustics & Sound (AREA)
  • Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0214993-1A 2001-12-07 2002-12-04 Processo para redução de acne ou aperfeiçoamento de tÈnus de pele BR0214993A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/012,627 US20020146469A1 (en) 2000-12-20 2001-12-07 Methods for reducing chronic stress in mammals
US10/017,180 US20020151527A1 (en) 2000-12-20 2001-12-07 Method for reducing acne or improving skin tone
PCT/US2002/038747 WO2003049769A2 (en) 2001-12-07 2002-12-04 Method for reducing acne or improving skin tone

Publications (1)

Publication Number Publication Date
BR0214993A true BR0214993A (pt) 2004-12-07

Family

ID=26683806

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214993-1A BR0214993A (pt) 2001-12-07 2002-12-04 Processo para redução de acne ou aperfeiçoamento de tÈnus de pele

Country Status (9)

Country Link
EP (1) EP1474170A1 (https=)
JP (1) JP2005517649A (https=)
KR (1) KR20040063166A (https=)
CN (1) CN1615152A (https=)
AU (2) AU2002359599A1 (https=)
BR (1) BR0214993A (https=)
CA (1) CA2469000A1 (https=)
MX (1) MXPA04005499A (https=)
WO (1) WO2003049769A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2329826A1 (en) * 2001-07-13 2011-06-08 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of multiple sclerosis
JP5388568B2 (ja) * 2005-03-30 2014-01-15 ルバンス セラピュティックス インク． ざ瘡を治療するための組成物及び方法
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
KR100861978B1 (ko) * 2007-03-22 2008-10-07 한국콜마 주식회사 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법
JP5522819B2 (ja) * 2008-01-29 2014-06-18 株式会社マンダム 抗菌性組成物及び皮膚外用剤
BRPI0910998A2 (pt) * 2008-07-17 2016-01-19 Georgia Levis composição para tratamento de acne e método para tratar acne
WO2012153884A1 (ko) * 2011-05-12 2012-11-15 (주)아모레퍼시픽 안정성이 향상된 여드름 개선용 조성물
JP5840437B2 (ja) * 2011-09-30 2016-01-06 日本メナード化粧品株式会社 抗炎症剤
CN106420787B (zh) * 2016-08-26 2020-05-26 陈启红 一种痤疮膏及其制备方法
US12150949B2 (en) 2018-07-30 2024-11-26 Curology, Inc. Compositions and methods of treating acne and photoaging

Also Published As

Publication number Publication date
JP2005517649A (ja) 2005-06-16
CA2469000A1 (en) 2003-06-19
AU2008203320A1 (en) 2008-08-21
MXPA04005499A (es) 2005-04-19
AU2002359599A1 (en) 2003-06-23
KR20040063166A (ko) 2004-07-12
EP1474170A1 (en) 2004-11-10
CN1615152A (zh) 2005-05-11
WO2003049769A2 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
Kumari et al. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma
El-On et al. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study
DE69929361T2 (de) Botulinumtoxine zur verstärkung der wundheilung
BR0013555A (pt) composições incluindo modafinila para tratamento da desordem da hiperatividade com déficit de atenção e fadiga por esclerose múltipla
BR0211062A (pt) Combinações para o tratamento de distúrbios inflamatórios
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
BR0214993A (pt) Processo para redução de acne ou aperfeiçoamento de tÈnus de pele
IT1255390B (it) Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione
BR0009647A (pt) Docetaxel em combinação com rhumab her2 para o tratamento de cânceres
BRPI0313792B8 (pt) utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
RU2007118663A (ru) Способ применения адапалена при поддерживающей терапии угревой сыпи
BR0312696A (pt) Tratamento tópico de doenças da pele
Iraji et al. Comparison between the efficacy of 10% zinc sulfate solution with 4% hydroquinone cream on improvement of melasma
WO2003057162A3 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
AU610587B2 (en) Treatment of aged skin with oral 13-cis-retinoic acid
Dogra et al. Comparative efficacy of 20% trichloroacetic acid and 50% glycolic acid peels in treatment of recalcitrant melasma
Ansari History of acne vulgaris and topical drugs in Unani medicine
Miškulin et al. New Topical Treatment of Symptomatic Internal Haemorrhoids in a General Practice Setting
MXPA05005021A (es) Pure de papaya y uso del mismo.
Joshi et al. A comprehensive review of herbal treatment of the species of spinach over the stages of acne vulgaris for research methodologies
Bhagwat et al. Efficacy and safety of 2% kojic acid containing formulation versus modified Kligman’ s formula in melasma-a comparative study
Freeman et al. Repeated verbal interruptions during exposure to complex transcerebral magnetic fields elicit irritability: Implications for opiate effects
Gul et al. Efficacy of combination therapy with topical fixed dose adapalene 0.1% and benzoyl peroxide 2.5% plus doxycycline 200 mg oral versus oral isotretinoin for the treatment of moderate to severe acne vulgaris
Lakhiwal et al. A REVIEW OF MUKHADUSHIKA WITH SPECIAL REFERENCE TO ACNE VULGARIS
Patel et al. Disorders of hypopigmentation and depigmentation

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1888 DE 13/03/2007.